Maintenance of body temperature is essential for the survival of homeotherms. Brown adipose tissue (BAT) is a specialized fat tissue that is dedicated to thermoregulation 1 . Owing to its remarkable capacity to dissipate stored energy and its demonstrated presence in adult humans [2] [3] [4] [5] , BAT holds great promise for the treatment of obesity and metabolic syndrome 1 . Rodent data suggest the existence of two types of brown fat cells: constitutive BAT (cBAT), which is of embryonic origin and anatomically located in the interscapular region of mice; and recruitable BAT (rBAT), which resides within white adipose tissue (WAT) 6 and skeletal muscle 7 , and has alternatively been called beige 8 , brite 9 or inducible BAT 10 . Bone morphogenetic proteins (BMPs) regulate the formation and thermogenic activity of BAT [10] [11] [12] . Here we use mouse models to provide evidence for a systemically active regulatory mechanism that controls whole-body BAT activity for thermoregulation and energy homeostasis. Genetic ablation of the type 1A BMP receptor (Bmpr1a) in brown adipogenic progenitor cells leads to a severe paucity of cBAT. This in turn increases sympathetic input to WAT, thereby promoting the formation of rBAT within white fat depots. This previously unknown compensatory mechanism, aimed at restoring total brown-fat-mediated thermogenic capacity in the body, is sufficient to maintain normal temperature homeostasis and resistance to diet-induced obesity. These data suggest an important physiological cross-talk between constitutive and recruitable brown fat cells. This sophisticated regulatory mechanism of body temperature may participate in the control of energy balance and metabolic disease.
It has recently become clear that cBAT shares a common developmental ancestry with skeletal muscle 13, 14 , whereas rBAT, localized within white fat or skeletal muscle, is derived from a non-myogenic lineage 10, 13 . Lineage-tracing experiments have also revealed that cBAT arises from progenitors located in the embryonic dermomyotome 15 that express the myogenic markers Pax7 and Myf5 (refs 13, 16) . Thus, we generated a mouse model lacking BMPR1A in all cells descending from the Myf5 1 lineage (Myf5-BMPR1A-KO). No apparent changes in morphology, proliferation or apoptosis were observed during early embryonic stages ( Supplementary Figs 1 and 2) . Histological evidence of reduced cBAT formation in Myf5-BMPR1A-KO mice was observed at embryonic day (E)16.5 and persisted until after birth (postnatal day (P)1; Fig. 1a -c). cBAT arises from highly proliferative fibroblasts during late gestational stages 17 . At E16.5, developing cBAT stains strongly for the proliferation marker Ki67, which was markedly decreased in Myf5-BMPR1A-KO embryos ( Fig. 1d and Supplementary Fig. 2b, d) . Apoptosis levels were unchanged in knockout mice compared to controls throughout embryogenesis ( Supplementary  Fig. 2c ), suggesting that reduced proliferation occurring before or around E16.5 is responsible for the defective formation of cBAT in knockout animals.
Myf5-BMPR1A-KO mice were born runted and stayed smaller throughout life ( Fig. 1e, f) . Importantly, the reduction of cBAT mass remained highly significant in adult mice ( Fig. 1g, h ). Despite this, the gene-expression pattern of the residual cBAT appeared normal, apart from a moderate reduction of Bmpr1a gene expression (Supplementary Fig. 3 ). The sizes of interscapular WAT (iWAT) and retroperitoneal WAT (rWAT)-two white-fat depots that contain subpopulations of cells from the Myf5 1 lineage 18 -were also reduced in the knockout mice ( Supplementary Fig. 4a ). Gene expression in iWAT showed a trend towards reduced expression of BAT genes, but there were no changes in the expression of general white adipogenic genes ( Supplementary Fig. 4b ). Subcutaneous WAT (sWAT) and epididymal WAT (eWAT), both mostly originating from a Myf5 2 lineage 18 , were not decreased in size and expressed normal levels of all type-1 BMP receptors (Fig. 1g, h and Supplementary  Fig. 3a -c). Expression of Bmpr1a in skeletal muscle, on the other hand, was reduced by .95% ( Supplementary Fig. 3a ). Upon normalization to body weight, we found that limb skeletal muscle size was unchanged, whereas the function of myogenic progenitors was altered (P.H. and E.G., unpublished data). Thus, loss of BMP signalling in Myf5-expressing cells specifically targets the formation of cBAT. During embryogenesis, MyoD 1 progenitors emerge after the Myf5 1 progenitors 19 . MyoD-Cre-driven Bmpr1a knockout mice showed completely normal development of cBAT and WAT depots (Supplementary Fig. 5 ), suggesting that the developmental divergence between myogenic and brown adipogenic progenitors takes place before the emergence of MyoD 1 progenitors, or that BMPR1A is not required for cBAT formation during this particular developmental stage.
A very similar phenotype was observed in a second mouse model with conditional deletion of Bmpr1a in all types of adipocytes (FABP4-BMPR1A-KO). Loss of Bmpr1a led to a specific paucity of cBAT as well as WAT-resident rBAT ( Supplementary Fig. 6 ). Because the FABP4-Cre driver is active at later adipogenic stages compared to Myf5-Cre, we conclude that signalling through BMPR1A is essential also for later stages of brown adipogenesis.
Next, we isolated progenitors from either Myf5 2 sWAT or Myf5 1 cBAT to test their cell-autonomous ability to produce brown adipocytes 10 . Cells derived from sWAT differentiated normally (Supplementary Fig. 7 ). By contrast, the frequency and ability of cBAT-derived Myf5 1 /Sca1 1 /CD31 2 (Sca1 also known as Ly6a; CD31 also known as Pecam1) progenitors to differentiate into mature brown adipocytes was significantly reduced ( Fig. 2a, b ). We therefore generated brown preadipocytes from cBAT completely lacking BMPR1A ( Supplementary  Fig. 8a, b ). Loss of Bmpr1a resulted in a marked inhibition of differentiation ( Fig. 2c ), and reduced ability to respond to BMP7-induced phosphorylation of SMAD and p38-mitogen-activated protein kinase (p38MAPK; also known as MAPK14) 20 , which are downstream targets Supplementary Fig. 1d ), and light microscopy of the same area (right panels: original magnification, 3400). Orange lines indicate brown fat. e, f, Body weight analysis of control (C) and Myf5-BMPR1A-KO (K) mice from P1 newborns (e; control: n 5 12; knockout: n 5 4) and adult mice (f; n 5 6). g, h, Analysis of cBAT, sWAT and eWAT weights after normalization to body weight (n 5 13). All data are presented as mean 6 standard error of the mean (s.e.m.) Asterisks denote significant differences between genotypes: **P , 0.01. of BMP signalling (Fig. 2d ). This led to a concomitant decrease in the expression of key adipogenic transcription factors zinc-finger protein 423 (Zfp423) 21 , CCAAT/enhancer-binding protein a (Cebpa) and peroxisome-proliferator-activated receptor c (Pparg) 22 in undifferentiated pre-adipocytes ( Fig. 2e ). After adipogenic differentiation, BMPR1Aknockout cells showed severely reduced expression of BAT markers Ucp1, PR-domain containing 16 (Prdm16) 13 and Pparg (Fig. 2f ), even in the presence of BMP7. Aside from BMPR1A, BMPR1B and activin A receptor, type 1 (ACVR1) are the other two major type-1 BMP receptors 20 . Whereas cBAT developed normally in whole-body BMPR1B-knockout mice ( Supplementary Fig. 9a, b ), deletion of Acvr1 in the Myf5 1 lineage resulted in a severe reduction of cBAT mass ( Supplementary Fig. 9c, d) , indicating that both ACVR1 and BMPR1A are essential for development of cBAT. Accordingly, pre-adipocytes lacking Acvr1 showed a somewhat milder phenotype compared to BMPR1Adeficient cells, whereas in double-knockout cells, brown adipogenesis was completely abolished ( Supplementary Fig. 8c-g) .
As BAT has a key role in thermoregulation, one would anticipate that the Myf5-BMPR1A-KO mice would have reduced body temperature as a consequence of impairment in cBAT development. Indeed, newborn Myf5-BMPR1A-KO mice, with their unfavourable surfaceto-volume ratio, showed a significant reduction in body temperature ( Fig. 3a, b ). This reduction in body temperature was, surprisingly, no longer present in adult Myf5-BMPR1A-KO mice maintained at normal ambient temperatures of 22 uC ( Fig. 3c , bars labelled 22 uC), indicating a compensatory mechanism that restored thermogenic capacity. Non-shivering thermogenesis is a critical response to prolonged cold exposure in order to maintain body temperature 23 . When exposed to acute and chronic cold challenges, control mice were able to quickly return to normal body temperature after 48 h of cold exposure, suggesting rapid activation of non-shivering thermogenesis via cBAT, and possibly other short-term measures such as muscle shivering, which are less pronounced in newborn mice. By contrast, Myf5-BMPR1A-KO mice showed a reduction in body temperature after 2 h and 48 h of cold exposure at 5 uC, presumably due to the paucity of cBAT ( Fig. 3c , bars labelled 5 uC/2 h and 5 uC/48 h), as we did not observe any abnormal behaviour, such as increased shivering, under cold exposure. Despite this, body temperature in Myf5-BMPR1A-KO mice returned to normal after prolonged cold exposure (that is, 11 days), strongly suggesting an adaptive recruitment of rBAT to cope with lower ambient temperatures ( Fig. 3c , bars labelled 5 uC/11 d). Accordingly, knockout animals showed a marked increase in UCP1 protein expression in sWAT ( Fig. 3d and Supplementary Fig. 10 ). This browning effect could be further enhanced in sWAT, and induced in eWAT, by administration of the b3-adrenergic receptor agonist CL-316,243, as indicated by significantly increased expression of BAT markers Ucp1 and celldeath-inducing DFFA-like effector a (Cidea) in Myf5-BMPR1A-KO mice ( Fig. 3e-h) , as well as by increased emergence of multilocular UCP1 1 adipocytes in WAT ( Fig. 3i, j) .
rBAT is sensitive to inductive factors, such as BMP7 (refs 10, 11), BMP8b 12 , fibroblast growth factor 21 (FGF21) 24 and the myokine irisin 25 (which is the processed and secreted form of the Fndc5 gene product), among others. However, gene expression analysis revealed no changes in any of these ( Supplementary Fig. 11 ), suggesting that the compensatory browning is not mediated by these factors. Because thermogenesis is rigorously controlled by the sympathetic nervous system 26, 27 , we quantified sympathetic input to white fat in Myf5-BMPR1A-KO mice. Staining for tyrosine hydroxylase was significantly increased in sWAT of knockout mice (Fig. 3k, l) . Moreover, circulating levels of noradrenaline were also significantly elevated in knockout mice, suggesting that increased sympathetic input may contribute to the browning of WAT in Myf5-BMPR1A-KO mice (Fig. 3m ). Additionally, cold-exposed Myf5-BMPR1A-KO mice showed normal noradrenaline-induced thermogenic capacity ( Fig. 3n and Supplementary  Fig. 12) , and thus possess a sufficient ability to compensate for loss of cBAT. These findings suggest that both types of brown fat may possess 
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similar capacities for thermoregulation if maximally stimulated. Whereas cBAT is essential during acute cold challenges, compensatory rBAT in the knockout mice with severe paucity of cBAT has a critical role in maintaining normal body temperature, especially during long-term cold exposure. In accordance with these findings, Myf5-BMPR1A-KO animals were resistant to diet-induced obesity, even under obesity-promoting thermoneutrality conditions, where mice no longer require thermogenesis to maintain body temperature 28 (Supplementary Fig. 13 ).
To determine whether the effect of compensatory browning is also present in other models of cBAT atrophy and independent of genetic intervention that could also affect skeletal muscle, we surgically interrupted innervation of cBAT in wild-type mice. Denervation of cBAT resulted in a significant decrease of cBAT size and a 68% reduction of Ucp1 expression in cBAT (P 5 0.0029; Fig. 4a, b) . As in Myf5-BMPR1A-KO mice, atrophy of cBAT resulted in increased recruitment of brown adipocytes in WAT ( Fig. 4c-e ), thus reinforcing the notion of a systemic mechanism that regulates total BAT-mediated thermogenic capacity.
It has been documented before that surgical removal of the interscapular depot of cBAT causes activation of the remaining depots of cBAT 29 . We used both genetic and surgically generated models of cBAT paucity to demonstrate the existence of a physiological mechanism to ensure thermoregulation by compensatory browning of WAT. This type of BAT may be more closely related to that found in adult humans 8 . The system inducing formation of rBAT seems to involve cBAT-brain and brain-WAT communication that is mediated, at least in part, by the sympathetic nervous system. Interestingly, obesity resistance in mice appears to be mostly related to browning of white fat, rather than adaptive thermogenesis of cBAT 30 , altogether suggesting that rBAT is a key contributor to metabolic health. The findings presented here suggest that any therapeutic approach involving rBAT must take into account the tight regulation of total-BAT-mediated thermogenic capacity and systemic energy metabolism at both peripheral and possibly also central levels. Targeting these mechanisms, for instance by modifying BMP signalling to regulate BAT mass and activity, could be a feasible approach to develop obesity therapies.
METHODS SUMMARY
Animal models. For conditional knockouts, strains expressing Cre recombinase under the control of Myf5, Myod or fatty-acid-binding protein 4 (Fabp4) promoters were crossed to mice carrying floxed alleles for Bmpr1a or Acvr1 (Myf5-Cre only). For some experiments, Myf5-BMPR1A-KO mice were crossed to a Rosa26-YFP reporter strain. For Bmpr1b, a strain with whole-body gene deletion was used. Denervation of cBAT in male, wild-type C57BL/6 mice was performed by isolating and removing a portion of about 1-2 mm from the intercostal nerve bundles innervating both lobes of the interscapular cBAT. Thermal imaging of skin-surface temperature. Measurement of skin temperature was performed using a thermal imaging camera (T300 InfraRed Camera; FLIR Systems) on newborn mice at ages P4-P6, before onset of hair growth. Statistical analysis. Results are expressed as mean 6 s.e.m. Differences between two groups were assessed using unpaired two-tailed Student's t-test or U-Mann-Whitney test. Data involving more than two groups were assessed by ANOVA. 34 Cre expression as indicated. For studies involving Bmpr1b deletion, animals with whole-body gene deletion of this receptor were used 35 . Myf5-Creexpressing animals were also crossed to Rosa26-YFP reporter mice (The Jackson Laboratory) in addition to the Bmpr1a-flox alleles for Myf5-lineage tracing and GFP labelling of Bmpr1a-deficient cells as described before 10 . For genotyping, DNA was isolated from tail tip biopsies by boiling in 0.5 ml 50 mM NaOH for 15 min, followed by neutralization by addition of 50 ml 1 M Tris-base (pH 6.8) and thorough vortexing. PCR genotyping was performed using primers as listed in Supplementary Table 1 . Expected band sizes for Bmpr1a during gel analysis were 180 bp for the wild-type allele and 230 bp for the floxed allele. For recombination analysis of Bmpr1a mRNA, expected band sizes were 396 and 233 bp for the intact and recombined alleles, respectively, and 178 bp for the control PCR of exons 6 to 7. For Acvr1 genotyping, the PCR product was subsequently digested using the restriction enzyme Bgl-I (New England Biolabs) at 37 uC overnight, yielding a band at 250 bp for wild-type mice, and a double band at 90 bp and 160 bp for floxed alleles (all three bands in heterozygotes). Expected band sizes for Bmpr1b were 350 bp for the wild type, and 300 bp for the null allele. Expected band sizes for the Rosa26-YFP reporter mice were 600 bp for the wild-type allele and 320 bp for the mutant allele. For Myf5-Cre genotyping, bands at 600 and 400 bp for wild-type and mutant alleles, respectively, were expected. For a general Cre PCR, a single band at approximately 350 bp indicated presence of Cre cDNA in the genome. For loading control, IRS-1 primers were added for co-amplification in the same reaction (band at approximately 500 bp) to ensure proper loading with template DNA.
To stimulate the browning of white adipose depots, mice were treated with daily intraperitoneal injections of 1 mg kg 21 bodyweight CL-316,243 (Sigma-Aldrich) dissolved in PBS (also used for control injections) for up to 10 days. For experiments involving high-fat-diet feeding, 4-to 6-week-old animals were placed on a diet containing 45 or 60% kilocalories from fat (Research Diets). For cold exposure and thermoneutral conditions, animals were housed at 5 uC or 30 uC, respectively, for the indicated times in a controlled environmental chamber (Caron Products & Services) with free access to food and water. Body core temperature was determined by rectal probe measurements.
Haematoxylin and eosin staining. Sections were prepared, processed and stained as described 11 .
Immunofluorescence. Sections were deparaffinized and prepared as described 11 . Primary antibodies were incubated overnight at 4 uC: Ki67 (1:200, rabbit polyclonal; Abcam); UCP1 (1:50, rabbit polyclonal; AnaSpec), tyrosine hydroxylase (1:50, rabbit polyclonal; Millipore), GFP (1:200, goat polyclonal; Novus USA). After primary antibody incubation, the sections were washed and incubated with appropriate secondary antibody (Alexa Fluor-488 (green) or -594 (red); Invitrogen) at a 1:200 dilution for 10 min in the dark. After secondary antibody incubation, sections were washed with distilled water for DAPI staining (0.1 mg ml 21 in water for 5-10 min in the dark), and mounted. Sections were kept in the dark after mounting and analysed by confocal microscopy on a Zeiss LSM-410 Invert Laser Scan Microscope (Carl Zeiss MicroImaging, Thornwood, NY), or using a fluorescence microscope (Olympus BX60F-3; Olympus Corporation). Quantification of tyrosine hydroxylase was performed by using the ImageJ software. Identical conditions and settings were used for picture acquisition and analysis. A threshold was set for each image to eliminate background and to create a binary mode image. A minimum particle size of 20 pixels was used as exclusion criteria to eliminate unspecific background and for quantification of areas that stained positive for tyrosine hydroxylase. For quantification of Ki67 staining, Ki67 1 nuclei were counted in areas identified as BAT by microscopic inspection of morphology and comparison to published sources 36 , and normalized to the total number of DAPI 1 nuclei in the same area. For each section and animal, images from three representative areas were analysed.
TdT-mediated dUTP nick end staining (TUNEL assay). For detection of DNA fragmentation, sections were deparaffinized and blocked for autofluorescence as described 10 . Sections were blocked in 1% BSA, 0.5-1% Triton X-100 in PBS for 1 h, followed by washes in PBS. Terminal-strand labelling was performed for 1.5 h at 37 uC in TdT buffer (30 mM Tris-HCl, 140 mM Na-Cacodylate, 1 mM cobalt (II) chloride, pH 7.2) in the presence of dATP, biotinylated dUTP and terminal deoxynucleotidyl transferase (all from Roche Applied Science). The reaction was stopped by immersion in 23 SSC buffer and subsequent incubation with Cy3-labelled streptavidin (1:200; Jackson ImmunoResearch Laboratories) for 1 h in the dark. Sections were then stained with DAPI, mounted, and analysed as described earlier.
RNA and protein quantification. RNA extraction, cDNA synthesis, and quantitative real-time PCR (qPCR) were performed as described before 11 . For qPCR analysis, C t values ,30 were used for gene expression analysis. Protein detection by western blotting was performed as described before 11 . Primary antibodies were incubated overnight at 4 uC: phospho-Smad-1/5/8 (1:1,000, rabbit polyclonal), SMAD1 (1:1,000, rabbit polyclonal), phospho-p38MAPK (1:1,000, rabbit polyclonal), p38MAPK (1:1,000, rabbit polyclonal) (all from Cell Signaling Technologies), UCP1 (1:500, goat polyclonal; Santa Cruz Biotechnology) and a-tubulin (1:8,000, mouse monoclonal; Sigma-Aldrich). HRP-coupled secondary antibodies (Cell Signaling Technologies) were used at 1:2,000 dilutions at room temperature for 2 h followed by detection using the ECL system. Cell sorting. Sca1 1 adipocyte progenitor cells were isolated from cBAT and sWAT of Myf5-BMPR1A-KO mice and control littermates, and differentiated as described before 10 .
Immortalized pre-adipocytes. Immortalized cell lines were generated as described previously 37 . In brief, cBAT from individual newborn pups (P1 or P2) of homozygous floxed parents for the respective BMP receptor was collected and pre-adipocytes were isolated by enzymatic digestion. Pre-adipocytes were immortalized by infection with SV40-expressing lentivirus and subsequent selection with puromycin. Stable cell lines were then infected with adenovirus expressing either GFP (control) or a Cre::GFP fusion construct for in vitro recombination (Gene Transfer Vector Core, University of Iowa). Forty-eight hours after infection, GFP 1 cells were collected by flow cytometry and expanded for subsequent use in experiments. DNA was isolated for PCR analysis to determine full recombination of the respective receptor gene using the primers as detailed earlier.
Cell culture. Pre-adipocyte cell lines were cultured as described before 11 , except that 2% fetal bovine serum was used during differentiation. BMP7 treatments (3.3 nM) were performed for 3 days before 48 h of adipogenic induction, followed by a differentiation period of 5 days. Oil-Red-O staining was performed as described before 11 . Thermal imaging of skin-surface temperature. Measurement of skin temperature was performed using a thermal imaging camera (T300 InfraRed Camera; FLIR Systems). Skin-surface temperature of newborns was analysed using FLIR Reporter 8.5 software (FLIR Systems). Images were acquired by placing newborn mice of the same litter (P4-P6) in 6-well cell-culture dishes, and 2-3 images of each mouse from different angles were acquired to minimize temperature variations due to different postures of the animal. Software drawing tools were used to draw a region of interest (ROI) around the entire animal, and average body surface temperature was calculated using that ROI. For each animal, an average temperature value of the temperatures from all single images was calculated. These averages were then used for statistical analysis. Serum parameters. Serum levels of noradrenaline were determined using a commercially available ELISA kit and according to the manufacturer's instructions (Norepinephrine (Research) ELISA; IBL America). To stabilize the noradrenaline, 1 mM EDTA and 4 mM sodium metabisulphite were added to the serum. Serum was prepared by spinning freshly collected blood in a cooled centrifuge at 6,000g for 20 min. The clear supernatant was collected and stored at 280 uC. Samples were analysed within 12 weeks after collection. To determine circulating irisin levels, a commercially available ELISA assay kit was used according to the manufacturer's specifications (Phoenix Pharmaceuticals). Body composition. Relative contents of lean and fat mass were determined using dual-energy X-ray absorptiometry (DEXA) according to the manufacturer's instructions (GE Lunar PIXImus 2, General Electric Medical Systems). Animals were anaesthetized with pentobarbital (50 mg kg 21 , intraperitoneally) and placed in the scanning area to measure body composition. Relative lean and fat mass were calculated by normalizing to body weight. Noradrenaline-induced thermogenic capacity. Measurement of maximum thermogenic capacity was performed as described before with some modifications 12, 28 . Animals were maintained in the cold as described earlier for 8 days before the experiment. All measurements were performed at room temperature. Oxygen consumption by indirect calorimetry was assessed using the Comprehensive Lab Animal Monitoring System (CLAMS; Columbus Instruments) and the Oxymax for Windows software (version 4.58) for data analysis. Animals were anaesthetized with pentobarbital (80 mg kg 21 , intraperitoneally), and indirect calorimetry was performed immediately for 30 min to record basal values of oxygen consumption. The sampling interval was set to 15 min to allow for stable oxygen consumption assessment throughout the experiment. After three data points were obtained, animals were briefly removed from the chamber and noradrenaline was injected subcutaneously (1 mg noradrenaline bitartrate per kg; Sigma-Aldrich), and oxygen consumption was recorded for another 90 min. To determine maximum noradrenaline-induced thermogenic capacity (DVO 2 ), the average value for basal oxygen consumption before noradrenaline injection was calculated and subtracted from the average value of highest noradrenalineinduced oxygen consumption (t 60 and t 75 ). Areas under the curve (AUC) were calculated for the curves after noradrenaline injection. Data were presented either RESEARCH LETTER
